API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/business/retail-consumer/european-regulators-close-big-tobaccos-new-tea-sticks-2024-03-28/
https://www.globenewswire.com/news-release/2024/03/28/2854501/0/en/Applied-Therapeutics-Provides-FDA-Update-on-PDUFA-Target-Action-Date-for-Govorestat-for-the-Treatment-of-Classic-Galactosemia.html
https://www.globenewswire.com//news-release/2024/02/28/2836879/0/en/Applied-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Govorestat-for-the-Treatment-of-Classic-Galactosemia.html
https://www.globenewswire.com//news-release/2024/02/15/2829821/0/en/Applied-Therapeutics-Announces-Positive-Results-from-12-month-Interim-Analysis-of-Govorestat-AT-007-in-the-Ongoing-INSPIRE-Phase-3-Trial-in-Sorbitol-Dehydrogenase-SORD-Deficiency.html
https://www.globenewswire.com//news-release/2024/01/03/2803176/0/en/Applied-Therapeutics-Announces-MAA-Validation-and-NDA-Submission-of-Govorestat-AT-007-for-Treatment-of-Classic-Galactosemia.html
https://www.globenewswire.com//news-release/2023/09/06/2738181/0/en/Applied-Therapeutics-Announces-Successful-Pre-NDA-Meeting-with-the-FDA-and-Confirms-Plans-to-Submit-NDA-for-Govorestat-AT-007-for-Treatment-of-Classic-Galactosemia-to-FDA-in-Q4-202.html
https://www.globenewswire.com/news-release/2023/05/25/2675970/0/en/Govorestat-AT-007-Receives-Orphan-Medicinal-Product-Designation-from-the-EMA-for-Treatment-of-SORD-Deficiency.html
https://www.pharmaceutical-technology.com/news/ema-orphan-medicinal-applied-at-007/